Vaccine

Details for Australian Patent Application No. 2009237648 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Ballou Jr., William Ripley; Hanon, Emmanuel Jules

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009237648

PCT Pub. Number WO2009/127677

Priority 61/045,292 16.04.08 US

Filing date 16 April 2009

Wipo publication date 22 October 2009

International Classifications

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/127677 Priority application(s): WO2009/127677

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237649-Indole modulators of the alpha 7 nicotinic acetylcholine receptor

2009237647-Vaccine